Skip to main content
. 2023 Nov 29;18:907. doi: 10.1186/s13018-023-04409-w

Table 2.

Comparison of factors affecting skeletal manifestations in patients with hemophilia

Variables Skeletal manifestations number (%)
Subgroups Fracture Synovitis Osteoporosis Target joint Osteoarthritis Bone disease
Severity of disease Severe 6 (7.5) 16 (20) 35 (43.8) 37 (46.3) 53 (66.3) 68 (85)
Non-severe 0 (0) 0 (0) 4 (20) 2 (10) 11 (55) 12 (60)
P value 0.59 0.03 0.07  < 0.001 0.43 0.02
Type of hemophilia A 6 (6.7) 14 (15.6) 35 (38.9) 39 (43.3) 59 (65.6) 74 (82.2)
B 0 (0) 2 (20) 4 (40) 0 (0) 5 (50) 6 (60)
P value  > 0.99 0.66  > 0.99  < 0.001 0.48 0.11
Treatment On-demand 6 (7.3) 11 (13.4) 30 (36.6) 35 (42.7) 55 (67.1) 68 (82.9)
prophylaxis 0 (0) 5 (27.8) 9 (50) 4 (22.2) 9 (50) 12 (66.7)
P value 0.588 0.158 0.301 0.120 0.186 0.189
History of hepatitis C infection Yes 4 (5.4) 13 (17.6) 29 (39.2) 21 (28.4) 45 (60.8) 56 (75.7)
No 2 (7.7) 3 (11.5) 10 (38.5) 18 (69.2) 19 (73.1) 24 (92.3)
P value 0.649 0.552  > 0.999  < 0.001 0.344 0.089
Active hepatitis C infection Yes 6 (7) 13 (15.1) 36 (41.9) 29 (33.7) 55 (64) 68 (79.1)
No 0 (0) 3 (21.4) 3 (21.4) 10 (71.4) 9 (64.3) 12 (85.7)
P value 0.591 0.693 0.237 0.015  > 0.999 0.730
Annual bleeding rate 1–3 2 (8.7) 1 (4.3) 10 (43.5) 4 (17.4) 12 (52.2) 13 (56.5)
4–6 1 (4.2) 4 (16.7) 10 (41.7) 8 (33.3) 17 (70.8) 22 (91.7)
 > 6 3 (5.7) 11 (20.8) 19 (35.8) 27 (50.9) 35 (66) 45 (84.9)
P value 0.740 0.221 0.795 0.019 0.357 0.004
Annual bleeding rate 1–3 2 (8.7) 1 (4.3) 10 (43.5) 4 (17.4) 12 (52.2) 13 (56.5)
 > 3 4 (5.2) 15 (19.5) 29 (37.7) 35 (45.5) 52 (67.5) 67 (87)
P value 0.619 0.109 0.634 0.016 0.218 0.003